Peptide dose ranges from published studies
Pick a peptide to see the lowest, most used and highest amounts that published studies gave, with a link to every study. Each peptide has a proof grade so you can see how strong the evidence is.
5-Amino-1MQ5A1MQ, 5-amino-1-methylquinolinium, NNMT inhibitorFat loss and aging muscle. In mice it cut body weight and fat, and grew stronger muscle in old mice. Not a peptide.Common use: 50 mg to 100 mg per doseAICARacadesine, AICA-riboside, AICA ribosideBlood sugar and how muscle uses fuel. In people it raised muscle sugar uptake and lowered liver sugar output. Not a peptide.Common use: 10 mg to 25 mg per doseAOD-9604AOD9604, hGH fragment 176-191 (Tyr-modified), Tyr-hGH 177-191Fat loss, from a piece of growth hormone. Cut weight gain in obese rats and mice. Also tested on knee cartilage in rabbits.Common use: 250 mcg to 500 mcg per doseARA-290cibinetide, pHBSP, pyroglutamate helix B surface peptideNerve pain and nerve damage, in sarcoidosis and diabetes. Human trials showed better nerve symptoms.Common use: 1 mg to 4 mg per doseB7-33single-chain relaxin-2 B-chain analogue, H2 relaxin B7-33Heart and lung scarring (fibrosis), from relaxin. Rat and mouse studies.Common use: 100 mcg to 750 mcg per doseBPC-157Body Protection Compound 157Healing of tendons, the gut and other tissue. Most studies are in rats. A few small human reports, such as knee pain and bladder pain.Common use: 250 mcg to 500 mcg per doseBronchogenAEDL, Ala-Glu-Asp-LeuThe lungs. In rats with COPD-like lung damage it reversed airway damage and lowered lung inflammation. No human trials.Common use: 10 mg per doseCagrilintideNN9838, AM833, long-acting amylin analogue (in CagriSema)Weight loss, alone and paired with semaglutide. Human trials showed lower body weight and HbA1c.Common use: 250 mcg to 4.5 mg per doseCardiogenAEDR, Ala-Glu-Asp-ArgThe heart. Grew heart tissue in a dish and slowed tumors in old rats. No human trials.Common use: 1 mg to 10 mg per doseCartalaxAED, Ala-Glu-Asp, T-31Cartilage and bone. Slowed bone loss in rats and helped old rat kidneys. No human trials.Common use: 700 mcg to 10 mg per doseChonlutenEDG, Glu-Asp-Gly, T-34The stomach and airways. Lowered inflammation signals in cells and helped stomach ulcer models. No human trials.Common use: 10 mg per doseCJC-1295CJC-1295 with DACRaising growth hormone and IGF-1 for days at a time. Tested in healthy adults.Common use: 100 mcg to 2 mg per doseCortagenAEDP, Ala-Glu-Asp-ProThe brain and nerves. Sped up nerve regrowth in rats and helped brain recovery. No human trials.Common use: 10 mg per doseDSIPdelta sleep-inducing peptide, emideltide, DeltaranSleep. Small human studies found longer, less broken sleep, including in people with insomnia.Common use: 100 mcg to 500 mcg per doseEpithalonEpitalon, AEDGAging and tumors. In mice and rats it lowered tumor rates. From the same Russian group as the bioregulators.Common use: 2 mg to 15 mg per doseFOXO4-DRIFOXO4 D-Retro-Inverso, FOXO4-DRI peptideClearing old, worn-out cells. In old mice, fitness, fur and kidney function came back.Common use: 250 mcg to 3 mg per doseGHK-CuCopper peptideSkin and wound healing. A copper peptide. Helped wounds close in rats. Human wound trials found little difference.Common use: 1 mg to 2 mg per doseGHRP-2Pralmorelin, KP-102, GPA-748Raising growth hormone, often used as a test of the pituitary. Human studies.Common use: 100 mcg to 300 mcg per doseGHRP-6Growth hormone releasing peptide 6, SK&F 110679Raising growth hormone. Human studies looked at how it works in the brain and how fast it clears.Common use: 100 mcg to 300 mcg per doseGonadorelinGnRH, LHRH, Factrel, Lutrepulse, KryptocurFertility. It triggers LH and FSH. Human studies helped restart periods and sperm making.Common use: 100 mcg to 300 mcg per doseHCGHuman chorionic gonadotropin, chorionic gonadotropin, Pregnyl, NovarelFertility and testosterone. An approved drug. Human studies raised testosterone inside the testes.Common use: 250 IU to 4,000 IU per doseHexarelinExamorelin, EP-23905Raising growth hormone, in young and older adults. Human studies.Common use: 100 mcg to 200 mcg per doseHGH Fragment 176-191AOD9604, AOD-9604, hGH fragment 177-191Fat loss, from the end piece of growth hormone. Cut weight and fat in obese rats and mice, and was tested on rabbit cartilage.Common use: 250 mcg to 500 mcg per doseHumaninHN, S14G-humanin, HNGProtecting cells under stress. Rat studies on the heart after a heart attack and on brain cells.Common use: 1 mg to 3 mg per doseIGF-1mecasermin, Increlex, rhIGF-I, insulin-like growth factor 1Growth and blood sugar. An approved drug for children who lack IGF-1. Human trials also tested it in diabetes.Common use: See schedule per doseIGF-1 DESdes(1-3)IGF-I, des-IGF-I, truncated IGF-IA shorter, faster-acting IGF-1. Rat studies on growth, weight gain and the gut lining.Common use: 30 mcg to 100 mcg per doseIGF-1 LR3LR3IGF-I, Long R3 IGF-I, long[Arg3] IGF-IA longer-lasting IGF-1. Rat studies on growth and weight gain.Common use: 20 mcg to 80 mcg per doseIpamorelinNNC 26-0161Raising growth hormone. Human studies showed a clean GH rise with no cortisol rise. Also tested for gut recovery after surgery.Common use: 200 mcg to 300 mcg per doseKisspeptin-10Metastin 45-54Turning on the hormones that run fertility (LH and FSH). Human studies in men and women.Common use: 100 mcg to 200 mcg per doseKPVLys-Pro-ValGut inflammation (colitis). In mice it calmed colitis. Also tested on eye surface healing in rabbits.Common use: 200 mcg to 500 mcg per doseLivagenKEDA, Lys-Glu-Asp-AlaThe liver and gut. In old rats it moved gut and liver cell activity toward young levels. No human trials.Common use: 1 mg to 5 mg per doseLL-37cathelicidin, hCAP-18 fragment, CAP18, ropocamptideFighting germs and healing leg ulcers. Human wound trials gave mixed results.Common use: 50 mcg to 300 mcg per doseMGFmechano growth factor, IGF-1Ec, MGF C24E, MGF C25E, PEG-MGFMuscle and tendon repair. Animal studies on cartilage, tendons and bruised muscle.Common use: 200 mcg to 400 mcg per doseMOTS-cMetabolism and exercise capacity. In mice it prevented weight gain on a fatty diet and improved running in old mice.Common use: 5 mg per doseNAD+Nicotinamide adenine dinucleotideCell energy and aging. Small human studies on how it moves through the body. Not a peptide.Common use: 20 mg to 100 mg per doseOvagenEDL, Glu-Asp-Leu, T-35The liver and kidneys. Protected rat kidneys from damage. No human trials.Common use: 10 mg per doseOxytocinPitocin, SyntocinonSocial behavior, including in autism and Prader-Willi syndrome. Large human trials mostly found no effect.Common use: 100 mcg to 400 mcg per dosePancragenKEDW, Lys-Glu-Asp-Trp-NH2, pancrageneThe pancreas and blood sugar. Lowered blood sugar in older people with diabetes and in monkeys.Common use: 10 mg per dosePinealonEDR, Glu-Asp-ArgThe brain. Small Russian human studies on mood and biological age markers.Common use: 200 mcg to 5 mg per doseProstamaxKEDP, Lys-Glu-Asp-ProThe prostate. Grew prostate tissue in a dish. No human trials.Common use: 10 mg per dosePT-141BremelanotideLow sexual desire. An approved drug for women (bremelanotide). Also tested for erections in men.Common use: 500 mcg to 2 mg per doseRetatrutideLY3437943Weight loss and type 2 diabetes. In human trials it lowered body weight and HbA1c (3-month blood sugar).Common use: 1 mg to 12 mg per doseSelankAnxiety. Russian human studies found it calmed anxiety about as well as a common anti-anxiety drug.Common use: 250 mcg to 400 mcg per doseSemaglutideType 2 diabetes, weight loss and heart risk. An approved drug. Human trials showed lower blood sugar, weight and fewer heart events.Common use: 250 mcg to 2.4 mg per doseSemaxStroke recovery and brain function. Russian human studies showed better recovery and higher BDNF after stroke.Common use: 300 mcg to 800 mcg per doseSermorelinGRF 1-29Raising growth hormone in older adults and in children who grow slowly. Raised night-time GH in human studies.Common use: 200 mcg to 500 mcg per doseSS-31ElamipretideMitochondria (the cell's energy makers). Human trials in heart failure and mitochondrial muscle disease.Common use: 5 mg to 40 mg per doseTB-500Thymosin Beta-4Tissue repair and wound healing, from thymosin beta-4. Human safety trials, plus animal heart and wound studies.Common use: 1 mg to 2 mg per doseTesamorelinTH9507Belly fat in people with HIV. An approved drug. It raises growth hormone and IGF-1 and cut deep belly fat in human trials.Common use: 1 mg to 2 mg per doseThymagenThymogen, Glu-Trp, EW dipeptide, oglufanide, IM862The thymus and immune system. Human trials in hepatitis C and cancer (as oglufanide) gave mixed results.Common use: 10 mcg to 10 mg per doseThymosin Alpha-1ThymalfasinBoosting the immune system. An approved drug in some countries. Human trials in hepatitis B and C.Common use: 1.6 mg to 3.2 mg per doseTirzepatideLY3298176Type 2 diabetes and weight loss. An approved drug. Human trials showed lower HbA1c and body weight.Common use: 2.5 mg to 15 mg per doseVesugenKED, Lys-Glu-Asp, vezugen, T-38Blood vessels. Small Russian human studies on biological age markers and mood.Common use: 10 mcg to 10 mg per doseVilonKE, Lys-GluThe immune system and aging. Longer life in mice, and added to diabetes care in Russian human studies.Common use: 100 mcg to 10 mg per dose
No peptide matches that search.